• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病在巴西圣保罗地区存在诊断不足和治疗不足的情况:PLATINO研究结果

Chronic obstructive pulmonary disease is underdiagnosed and undertreated in São Paulo (Brazil): results of the PLATINO study.

作者信息

Nascimento O A, Camelier A, Rosa F W, Menezes A M B, Pérez-Padilla R, Jardim J R

机构信息

Disciplina de Pneumologia e Centro de Reabilitação Pulmonar, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.

出版信息

Braz J Med Biol Res. 2007 Jul;40(7):887-95. doi: 10.1590/s0100-879x2006005000133.

DOI:10.1590/s0100-879x2006005000133
PMID:17653440
Abstract

Chronic obstructive pulmonary disease (COPD) is a common disease in adults over 40 years of age and has a great social and economic impact. It remains little recognized and undertreated even in developed countries. However, there are no data about its diagnosis and treatment in Brazil. The objectives of the present study were to evaluate the proportion of COPD patients who had never been diagnosed and to determine if the COPD patients who had been identified were receiving appropriate treatment. The Latin American Project for the Investigation of Obstructive Lung Disease (PLATINO) was a randomized epidemiological study of adults over 40 years living in five metropolitan areas, including São Paulo. The studied sample was randomly selected from the population after a division of the metropolitan area of São Paulo in clusters according to social characteristics. All subjects answered a standardized questionnaire on respiratory symptoms, history of smoking, previous diagnosis of lung disease, and treatments. All subjects performed spirometry. The criterion for the diagnosis of COPD was defined by a post-bronchodilator FEV1/FVC ratio lower than 0.7. A total of 918 subjects were evaluated and 144 (15.8%) met the diagnostic criterion for COPD. However, 126 individuals (87.5%) had never been diagnosed. This undiagnosed group of COPD patients had a lower proportion of subjects with respiratory symptoms than the previously diagnosed patients (88.9 vs 54.8%) and showed better lung function with greater FEV1 (86.8 +/- 20.8 vs 68.5 +/- 23.6% predicted) and FVC (106.6 +/- 22.4 vs 92.0 +/- 24.1% predicted). Among the COPD patients, only 57.3% were advised to stop smoking and 30.6% received the influenza vaccine. In addition, 82.3% did not receive any pharmacological treatment. In conclusion, COPD is underdiagnosed and a large number of COPD patients are not treated appropriately.

摘要

慢性阻塞性肺疾病(COPD)是40岁以上成年人中的常见疾病,具有重大的社会和经济影响。即使在发达国家,它仍然鲜为人知且治疗不足。然而,巴西尚无关于其诊断和治疗的数据。本研究的目的是评估从未被诊断出的COPD患者的比例,并确定已确诊的COPD患者是否正在接受适当的治疗。拉丁美洲阻塞性肺病调查项目(PLATINO)是一项针对居住在包括圣保罗在内的五个大都市地区的40岁以上成年人的随机流行病学研究。在根据社会特征将圣保罗大都市区划分为多个集群后,从人群中随机选取研究样本。所有受试者均回答了一份关于呼吸道症状、吸烟史、既往肺病诊断和治疗情况的标准化问卷。所有受试者均进行了肺功能测定。COPD的诊断标准定义为支气管扩张剂后FEV1/FVC比值低于0.7。总共评估了918名受试者,其中144名(15.8%)符合COPD的诊断标准。然而,126人(87.5%)从未被诊断出。这组未被诊断出的COPD患者出现呼吸道症状的比例低于先前诊断出的患者(88.9%对54.8%),并且肺功能更好,FEV1(预测值的86.8±20.8%对68.5±23.6%)和FVC(预测值的106.6±22.4%对92.0±24.1%)更高。在COPD患者中,只有57.3%被建议戒烟,30.6%接种了流感疫苗。此外,82.3%未接受任何药物治疗。总之,COPD诊断不足,大量COPD患者未得到适当治疗。

相似文献

1
Chronic obstructive pulmonary disease is underdiagnosed and undertreated in São Paulo (Brazil): results of the PLATINO study.慢性阻塞性肺疾病在巴西圣保罗地区存在诊断不足和治疗不足的情况:PLATINO研究结果
Braz J Med Biol Res. 2007 Jul;40(7):887-95. doi: 10.1590/s0100-879x2006005000133.
2
The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities.普拉蒂诺项目:拉丁美洲主要城市慢性阻塞性肺疾病多中心患病率调查方法
BMC Med Res Methodol. 2004 Jun 17;4:15. doi: 10.1186/1471-2288-4-15.
3
Prevalence of chronic obstructive pulmonary disease and associated factors: the PLATINO Study in São Paulo, Brazil.慢性阻塞性肺疾病的患病率及相关因素:巴西圣保罗的PLATINO研究
Cad Saude Publica. 2005 Sep-Oct;21(5):1565-73. doi: 10.1590/s0102-311x2005000500030. Epub 2005 Sep 12.
4
[Treatment of chronic obstructive pulmonary disease in 5 Latin American cities: the PLATINO study].[拉丁美洲5个城市慢性阻塞性肺疾病的治疗:PLATINO研究]
Arch Bronconeumol. 2008 Feb;44(2):58-64. doi: 10.1016/s1579-2129(08)60016-6.
5
PLATINO, a nine-year follow-up study of COPD in the city of São Paulo, Brazil: the problem of underdiagnosis.PLATINO,巴西圣保罗市一项为期九年的 COPD 随访研究:漏诊问题。
J Bras Pneumol. 2014 Jan-Feb;40(1):30-7. doi: 10.1590/S1806-37132014000100005.
6
External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population.在一般实践样本和 PLATINO 研究人群中对 PUMA COPD 诊断问卷进行外部验证。
Int J Chron Obstruct Pulmon Dis. 2019 Aug 26;14:1901-1911. doi: 10.2147/COPD.S206250. eCollection 2019.
7
Incidence of chronic obstructive pulmonary disease based on three spirometric diagnostic criteria in Sao Paulo, Brazil: a nine-year follow-up since the PLATINO prevalence study.基于三种肺功能诊断标准的巴西圣保罗慢性阻塞性肺疾病发病率:PLATINO患病率研究后的九年随访
Sao Paulo Med J. 2015 May-Jun;133(3):245-51. doi: 10.1590/1516-3180.2015.9620902. Epub 2015 Jun 1.
8
A population-based cohort study on chronic obstructive pulmonary disease in Latin America: methods and preliminary results. The PLATINO Study Phase II.基于人群的拉丁美洲慢性阻塞性肺疾病队列研究:方法和初步结果。PLATINO 研究第二阶段。
Arch Bronconeumol. 2014 Jan;50(1):10-7. doi: 10.1016/j.arbres.2013.07.014. Epub 2013 Dec 12.
9
Diagnostic labeling of COPD in five Latin American cities.拉丁美洲五个城市慢性阻塞性肺疾病的诊断标签
Chest. 2007 Jan;131(1):60-7. doi: 10.1378/chest.06-1149.
10
Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study.拉丁美洲五个城市的慢性阻塞性肺疾病(PLATINO研究):一项患病率研究。
Lancet. 2005 Nov 26;366(9500):1875-81. doi: 10.1016/S0140-6736(05)67632-5.

引用本文的文献

1
Challenges and Opportunities in COPD Management in Latin America: A Review of Inhalation Therapies and Advanced Drug Delivery Systems.拉丁美洲慢性阻塞性肺疾病管理中的挑战与机遇:吸入疗法和先进药物递送系统综述
Pharmaceutics. 2024 Oct 11;16(10):1318. doi: 10.3390/pharmaceutics16101318.
2
Increasing patient access to spirometry in the Unified Health System in Brazil: no longer a dream but a near reality.在巴西统一卫生系统中增加患者使用肺活量测定法的机会:不再是梦想,而是接近现实。
J Bras Pneumol. 2024 Jan 15;49(6):e20230384. doi: 10.36416/1806-3756/e20230384.
3
Case-Finding tool for COPD in LMIC (COLA) - translation and cross-cultural adaptation into Brazilian Portuguese language.
用于中低收入国家 COPD 的筛查工具(COLA)- 翻译成巴西葡萄牙语并进行跨文化适应性调整。
Rev Saude Publica. 2023 Oct 20;57:63. doi: 10.11606/s1518-8787.2023057004904. eCollection 2023.
4
Characteristics and difference of respiratory diseases in Korean adults aged ≥40 years: A cross-sectional study.韩国≥40 岁成年人呼吸系统疾病的特征和差异:一项横断面研究。
Clin Respir J. 2023 Jan;17(1):29-39. doi: 10.1111/crj.13558. Epub 2022 Nov 15.
5
The Importance of Inhaler Adherence to Prevent COPD Exacerbations.吸入器依从性对预防慢性阻塞性肺疾病急性加重的重要性。
Med Sci (Basel). 2019 Apr 1;7(4):54. doi: 10.3390/medsci7040054.
6
Management of COPD within the Brazilian Unified Health Care System in the state of Bahia: an analysis of real-life medication use patterns.巴西巴伊亚州统一医疗保健系统中慢性阻塞性肺疾病的管理:实际用药模式分析
J Bras Pneumol. 2019 Feb 11;45(1):e20170194. doi: 10.1590/1806-3713/e20170194.
7
Chronic Obstructive Pulmonary Disease in Latin America.慢性阻塞性肺疾病在拉丁美洲。
Ann Glob Health. 2019 Jan 22;85(1):7. doi: 10.5334/aogh.2418.
8
New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology.慢性阻塞性肺疾病支气管扩张剂治疗优化的新进展:聚焦于通过共悬浮给药技术配制的格隆溴铵/福莫特罗组合制剂
Int J Chron Obstruct Pulmon Dis. 2018 Sep 7;13:2805-2819. doi: 10.2147/COPD.S113306. eCollection 2018.
9
Prevalence and features of asthma-COPD overlap in the United States 2007-2012.2007 - 2012年美国哮喘 - 慢性阻塞性肺疾病重叠综合征的患病率及特征
Clin Respir J. 2018 Aug;12(8):2369-2377. doi: 10.1111/crj.12917.
10
Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis.描述未诊断的慢性阻塞性肺疾病的特征:系统评价和荟萃分析。
Respir Res. 2018 Feb 7;19(1):26. doi: 10.1186/s12931-018-0731-1.